Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Observational Study of Gut Microbiota Changes and Serum Phosphate Reduction With Tenapanor in Maintenance Hemodialysis Patients
jRCT1041260116Active, not recruiting
- Sponsor
- Akihiko Koshino
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tenapanor in hyperphosphatemia, sponsored by Akihiko Koshino. Started Apr 2024; status: active, not recruiting.
02
Drugs
tenapanor
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on jRCT1041260116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041260116.